-- Trulieve Cannabis (TRUL.CN) on Wednesday said it applied to the US Drug Enforcement Administration (DEA) to register some of its state-licensed medical-marijuana operations.
The applications were filed under a new expedited process established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act, the company added.
Under the new rules, eligible operators that apply within 60 days are automatically approved to manufacture, distribute, and sell these products unless the DEA says otherwise, according to the statement.
"With over 200 dispensaries serving only medical patients, Trulieve is uniquely positioned to set the bar as a responsible operator in U.S. cannabis," Chief Executive Kim Rivers said.
Price: $13.19, Change: $-0.50, Percent Change: -3.65%